Personally, not frustrated at all. Content to sit back and watch developments over the next few years.
- Forums
- ASX - By Stock
- EYE
- CMS Proposes Major Increase in Reimbursement for Canaloplasty
CMS Proposes Major Increase in Reimbursement for Canaloplasty, page-189
-
-
- There are more pages in this discussion • 319 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EYE (ASX) to my watchlist
(20min delay)
|
|||||
Last
16.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $36.64M |
Open | High | Low | Value | Volume |
16.0¢ | 16.0¢ | 15.5¢ | $39.30K | 249.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 80000 | 15.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
16.0¢ | 114260 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 80000 | 0.155 |
5 | 137000 | 0.150 |
8 | 558724 | 0.145 |
10 | 407230 | 0.140 |
2 | 14500 | 0.135 |
Price($) | Vol. | No. |
---|---|---|
0.160 | 114260 | 3 |
0.165 | 119997 | 2 |
0.170 | 200000 | 3 |
0.175 | 100000 | 1 |
0.180 | 100000 | 1 |
Last trade - 13.44pm 13/11/2024 (20 minute delay) ? |
Featured News
EYE (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online